Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: A retrospective analysis over 15 years

Acta Psychiatrica Scandinavica

Volumn 93, Issue 5, 1996, Pages 349-354

  Berghofer A ^a   Kossmann, B ^a   Muller Oerlinghausen B ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

affective disorder; lithium; long term treatment; morbidity; recurrence

Indexed keywords

LITHIUM;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; LITHIUM BLOOD LEVEL; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 0029980036     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb10659.x     Document Type: Article

References (32)

1. BAASTRUP PC. The use of lithium in manic-depressive psychosis. Compr Psychiatry 1964: 5: 396-408.
2. PRIEN RF, KLETT J, CAFFEY EM JR. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 1973: 29: 420-425.
3. SCHOU M. Lithium as a prophylactic agent in unipolar affective illness. Arch Gen Psychiatry 1979: 36: 849-851.
4. KANE JM, QUITKIN FM, RIFKIN A, RAMOS-LORENZI JR, NAYAK DD, HOWARD A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. A prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982: 39: 1065-1069.
5. MORRISON DP, McCREADIE RG. The impact of lithium in south-west Scotland. II. A longitudinal study. Br J Psychiatry 1985: 146: 74-77.
6. AAGAARD J, VESTERGAARD P. Predictors of outcome in prophylactic lithium treatment. A 2-year prospective study. J Affect Dis 1990: 18: 259-266.
7. SCHOU M. Lithium prophylaxis: about 'naturalistic' or 'clinical practice' studies. Lithium 1993: 4: 77-81.
8. GOODWIN GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 1994: 164: 149-152.
9. MÜLLER-OERLINGHAUSEN B, AHRENS B, GROF E et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992: 86: 218-222.
10. AHRENS B, MÜLLER-OERLINGHAUSEN B, GROF P. Length of lithium treatment needed to eliminate the high mortality of affective disorders. Br J Psychiatry 1993: 163 (Suppl. 21): 27-29.
11. FELBER W. Rezidivprophylaxe affektiver Erkrankungen mit Lithium. Multicenter-Studie Lithiumtherapie bei 850 Patienten. Regensburg: S. Roderer, 1993.
12. CAZZULLO CL, SACCHETTI E. Critical issues in the evaluation of longterm lithium-treatment. In: CORSINI GU, ed. Current trends in lithium and rubidium therapy. Lancaster: MTP Press, 1984: 95-110.
13. NILSSON A, AXELSSON R. Psychopathology during long-term lithium treatment of patients with major affective disorders. Acta Psychiatr Scand 1989: 80: 375-388.
14. ANGST J. Ungelöste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver und schizoaffektiver Erkrankungen. Biblthca Psychiatria 1981: 161: 32-44.
15. KÜFFERLE B, LENZ G. Classification and course of schizoaffective psychosis. Follow-up of patients treated with lithium. Psychiatr Clin 1983: 16: 169-177.
16. GREIL W, LUDWIG-MAYERHOFER W, STELLER B et al. Lithium- oder Carbamazepinprophylaxe bei affektiven Psychosen? Ergebnisse einer kontrollierten, multizentrischen Studie. In: MÜLLER-OERLINGHAUSEN B and BERGHÖFER A, ed. Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart: Georg Thieme Verlag, 1994: 113-119.
17. MÜLLER-OERLINGHAUSEN B, THIES K, VOLK J. Lithium in treatment and prophylaxis of affective and schizoaffective disorders. In: MARNEROS A AND TSUANG MT, ed. Affective and schizoaffective disorders. Berlin, Heidelberg: Springer-Verlag, 1990: 251-261.
18. MÜLLER-OERLINGHAUSEN B, KOSSMANN B, VOLK J, HERRMANN H. Characteristics of recurrences during ten years of lithium prophylaxis. In: BIRCH NJ, ed. Lithium: inorganic pharmacology and psychiatric use. Oxford: IRL Press Limited, 1988.
19. Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie, ed. Das AMDP-System. 4. Aufl. Berlin, Heidelberg, New York: Springer Verlag, 1981.
20. COPPEN A, ABOU-SALEH MT. Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry 1982: 141: 87-89.
21. WEISSENBORN I, MÜLLER-OERLINGHAUSEN B. Vergleich der Wirkungen von Lithiumsalzen bei zwei zu verschiedenen Zeiten rekrutierten Patientenstichproben: Ein Beispiel für methodische Probleme von Ultralangzeitstudien. In: MÜLLER-OERLINGHAUSEN B and BERGHÖFER A, ed. Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart: Georg Thieme Verlag, 1994: 13-23.
22. KOUFEN H, CONSBRUCH U. Langzeitkatamnese zur Frage von Nutzen und Nebenwirkungen der Lithiumprophylaxe der phasischen Psychosen. Fortschr Neurol Psychiatry 1989: 57: 374-382.
23. VESTERGAARD P, SCHOU M. Prospective studies on a lithium cohort. I. General features. Acta Psychiatr Scand 1988: 78: 421-426.
24. NILSSON A, AXELSSON R. Lithium discontinuers. I. Clinical characteristics and outcome. Acta Psychiatr Scand 1990: 82: 433-438.
25. COPPEN A, ABOU-SALEH MT. Lithium therapy: from clinical trials to practical management. Acta Psychiatr Scand 1988: 78: 754-762.
26. SURTEES PG, BARKLEY C. Future imperfect: the long-term outcome of depression. Br J Psychiatry 1994: 164: 327-341.
27. HARROW M, GOLDBERG JF, GROSSMAN LS, MELTZER HY. Outcome in manic disorders. A naturalistic follow-up study. Arch Gen Psychiatry 1990: 47: 665-671.
28. GOLDBERG JF, HARROW M, GROSSMAN LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 1995: 152: 379-384.
29. MÜLLER-OERLINGHAUSEN B, MÜSER-CAUSEMANN B, VOLK J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Dis 1992: 25: 261-270.
30. AHRENS B, MÜLLER-OERLINGHAUSEN B, SCHOU M et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Dis 1995: 33: 67-75.
31. LENZ G, AHRENS B, DENK E et al. Mortalität nach Ausscheiden aus der Lithiumambulanz. In: MÜLLER-OERLINGHAUSEN B and BERGHÖFER A, ed. Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart: Georg Thieme Verlag, 1994: 49-52.
32. HIMMELHOCH JM, NEIL JF, MAY SJ, FUCHS CZ, LICATA SM. Age, dementia, dyskinesias and lithium response. Am J Psychiatry 1980: 137: 941-945.